| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.037 | 0.8 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |